Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities
The excessive accumulation of lipids in hepatocytes induces a type of cytotoxicity called hepatic lipotoxicity, which is a fundamental contributor to liver metabolic diseases (such as NAFLD). Magnesium isoglycyrrhizinate (MGIG), a magnesium salt of the stereoisomer of natural glycyrrhizic acid, is w...
Main Authors: | Li Lu, Kun Hao, Yu Hong, Jie Liu, Jinwei Zhu, Wenjiao Jiang, Zheying Zhu, Guangji Wang, Ying Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5884 |
Similar Items
-
Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection
by: LI Xiaohui, et al.
Published: (2016-01-01) -
Magnesium isoglycyrrhizinate positively affects concanavalin A-induced liver damage by regulating macrophage polarization
by: Rui Lin, et al.
Published: (2018-01-01) -
Magnesium isoglycyrrhizinate protects against concanavalin A-induced immunological liver injury in a mouse model
by: Jiang Zhengyan, et al.
Published: (2019-07-01) -
Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2
by: Jie Kai Tee, et al.
Published: (2018-09-01) -
Magnesium isoglycyrrhizinate ameliorates radiation-induced pulmonary fibrosis by inhibiting fibroblast differentiation via the p38MAPK/Akt/Nox4 pathway
by: Qunfang Yang, et al.
Published: (2019-07-01)